Hindiyeh, N. A., Kellerman, D. J. and Schmidt, P. C. (2019), Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials. Headache: The Journal of Head and Face Pain, 59: 819‐824. doi: https://doi.org/10.1111/head.13511
The authors report that the drug lasmiditan was spelled incorrectly in the tables as “lasmitidan.”